Could FDA recommend new antibiotic for hospital-acquired pneumonia?
A new combination antibiotic for hospital-acquired pneumonia offers advantages in dosing and tolerability, a Phase III trial has shown.
List view / Grid view
A new combination antibiotic for hospital-acquired pneumonia offers advantages in dosing and tolerability, a Phase III trial has shown.
According to Rutgers researchers, physicians are scaling back on prescribing antibiotics for long-term acne treatment in favour of a combination of therapies.